StockData
MannKind Corp logo

MannKind Corp (MNKD) stock

MNKDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30127% above fair value
$4.07+0.00 (0.00%)

Close on Nov 18, 2026Market cap $1.31BP/E –Yield –

MannKind operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

MannKind's operating income for the twelve months ending Jun 30, 2026 was $9.19M, down 86.2% year over year. For fiscal 2025 it was $38.80M, down 46.5% from the year before. The highest annual figure on record is $72.59M in fiscal 2024.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025$38.80M-46.5%
FY2024Dec 31, 2024$72.59M+736.4%
FY2023Dec 31, 2023$8.68M–
FY2022Dec 31, 2022-$64.11M–
FY2021Dec 31, 2021-$47.02M–
FY2020Dec 31, 2020-$47.91M–
FY2019Dec 31, 2019-$44.60M–
FY2018Dec 31, 2018-$76.60M–
FY2017Dec 31, 2017-$108.19M-260.9%
FY2016Dec 31, 2016$67.26M–
FY2015Dec 31, 2015-$344.66M–
FY2014Dec 31, 2014-$179.63M–
FY2013Dec 31, 2013-$169.40M–
FY2012Dec 31, 2012-$146.96M–
FY2011Dec 31, 2011-$140.54M–
FY2010Dec 31, 2010-$152.50M–
FY2009Dec 31, 2009-$209.78M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$350.00K-106.6%
Q1 FY2026Mar 31, 2026-$1.67M-107.5%
Q4 FY2025Dec 31, 2025-$7.69M-129.0%
Q3 FY2025Sep 30, 2025$18.90M+48.1%
Q2 FY2025Jun 30, 2025$5.30M-68.1%
Q1 FY2025Mar 31, 2025$22.29M+33.3%
Q4 FY2024Dec 31, 2024$26.50M+237.2%
Q3 FY2024Sep 30, 2024$12.76M+150.3%
Q2 FY2024Jun 30, 2024$16.61M+865.1%
Q1 FY2024Mar 31, 2024$16.72M–
Q4 FY2023Dec 31, 2023$7.86M–
Q3 FY2023Sep 30, 2023$5.10M–
Q2 FY2023Jun 30, 2023$1.72M–
Q1 FY2023Mar 31, 2023-$6.00M–
Q4 FY2022Dec 31, 2022-$12.79M–
Q3 FY2022Sep 30, 2022-$9.61M–
Q2 FY2022Jun 30, 2022-$20.45M–
Q1 FY2022Mar 31, 2022-$21.26M–
Q4 FY2021Dec 31, 2021-$23.97M–
Q3 FY2021Sep 30, 2021-$6.59M–
Q2 FY2021Jun 30, 2021-$10.27M–
Q1 FY2021Mar 31, 2021-$6.19M–
Q4 FY2020Dec 31, 2020-$23.75M–
Q3 FY2020Sep 30, 2020-$9.13M–
Q2 FY2020Jun 30, 2020-$7.92M–
Q1 FY2020Mar 31, 2020-$7.12M–
Q4 FY2019Dec 31, 2019-$11.35M–
Q3 FY2019Sep 30, 2019-$8.78M–
Q2 FY2019Jun 30, 2019-$10.95M–
Q1 FY2019Mar 31, 2019-$13.51M–
Q4 FY2018Dec 31, 2018-$7.73M–
Q3 FY2018Sep 30, 2018-$21.54M–
Q2 FY2018Jun 30, 2018-$20.54M–
Q1 FY2018Mar 31, 2018-$26.79M–
Q4 FY2017Dec 31, 2017-$28.84M–
Q3 FY2017Sep 30, 2017-$28.18M-123.8%
Q2 FY2017Jun 30, 2017-$31.57M–
Q1 FY2017Mar 31, 2017-$19.60M–
Q4 FY2016Dec 31, 2016-$11.83M–
Q3 FY2016Sep 30, 2016$118.23M–

More MannKind figures

See a number that looks wrong?